Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
34(10)
Published: Nov. 29, 2023
Abstract
Here,
the
development
of
chiral
D
‐/
L
‐Cu
x
OS
nanoparticle‐engineered
metal–organic
frameworks
(Fe‐MIL‐88B‐NH
2
),
denoted
as
OS@Fe‐MOFs,
for
cuproptosis
and
ferroptosis
synergistic
therapy
is
described.
The
OS@Fe‐MOF
displayed
intense
circular
dichroism
(CD)
bands
at
488
nm
due
to
chirality
transfer
from
penicillamine
ligands.
Chiral
showed
tumor
microenvironment‐triggered
catalytic
therapeutic
activity
by
simultaneously
depleting
‐glutathione
(GSH)
generating
potent
reactive
oxygen
species
in
cancer
cells.
In
vivo
experimental
results
synchronously
demonstrated
with
higher
efficiency
therapy.
findings
revealed
that
copper/iron
ions
released
induced
augmented
oxidative
stress
ferroptosis,
which
synergizes
enhanced
index
determined
be
1.94,
while
D,L
1.75
1.84,
respectively.
To
best
knowledge,
this
first
report
a
nanomaterial
capable
inducing
ferroptosis‐cuproptosis
cancers.
should
invigorate
studies
pursuing
rational
design
nanomaterials
efficacious
based
on
ferroptosis.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(15), P. 5386 - 5417
Published: Jan. 1, 2023
Stimuli-activatable
strategies
prevail
in
the
design
of
nanomedicine
for
cancer
theranostics.Upon
exposure
to
endogenous/exogenous
stimuli,
stimuli-activatable
could
be
self-assembled,
disassembled,
or
functionally
activated
improve
its
biosafety
and
diagnostic/therapeutic
potency.A
myriad
tumor-specific
features,
including
a
low
pH,
high
redox
level,
overexpressed
enzymes,
along
with
exogenous
physical
stimulation
sources
(light,
ultrasound,
magnet,
radiation)
have
been
considered
nano-medicinal
products.Recently,
novel
stimuli
explored
elegant
designs
emerged
nanomedicine.In
addition,
multi-functional
theranostic
has
employed
imaging-guided
image-assisted
antitumor
therapy.In
this
review,
we
rationalize
development
clinical
pressing
needs.Stimuli-activatable
self-assembly,
disassembly
functional
activation
approaches
developing
realize
better
efficacy
are
elaborated
state-of-the-art
advances
their
structural
detailed.A
reflection,
status,
future
perspectives
provided.
Chemical Society Reviews,
Journal Year:
2023,
Volume and Issue:
52(6), P. 2031 - 2081
Published: Jan. 1, 2023
Bioactive
materials
are
a
special
class
of
biomaterials
that
can
react
in
vivo
to
induce
biological
response
or
regulate
functions,
thus
achieving
better
curative
effect
than
traditional
inert
biomaterials.
For
cancer
theranostics,
compared
with
organic
polymer
nanomaterials,
inorganic
nanomaterials
possess
unique
physical
and
chemical
properties,
have
stronger
mechanical
stability
on
the
basis
maintaining
certain
bioactivity,
easy
be
compounded
various
carriers
(polymer
carriers,
etc.),
so
as
achieve
specific
antitumor
efficacy.
After
entering
nanoscale,
due
nano-size
effect,
high
surface
area
nanostructures,
exhibit
effects,
which
significantly
influence
interaction
organisms.
Therefore,
research
applications
bioactive
theranostics
attracted
wide
attention.
In
this
review,
we
mainly
summarize
recent
progress
also
introduce
definition,
synthesis
modification
strategies
nanomaterials.
Thereafter,
tumor
imaging
therapy,
including
microenvironment
(TME)
regulation,
catalytic
gas
regulatory
cell
death
immunotherapy,
discussed.
Finally,
biosafety
challenges
mentioned,
their
future
development
opportunities
prospected.
This
review
highlights
bioapplication
Angewandte Chemie International Edition,
Journal Year:
2023,
Volume and Issue:
62(35)
Published: Feb. 25, 2023
Abstract
Understanding
the
intricate
molecular
machinery
that
governs
ferroptosis
and
leveraging
this
accumulating
knowledge
could
facilitate
disease
prevention,
diagnosis,
treatment,
prognosis.
Emerging
approaches
for
in
situ
detection
of
major
regulators
biological
events
across
cellular,
tissue,
living
subjects
provide
a
multiscale
perspective
studying
ferroptosis.
Furthermore,
advanced
applications
integrate
latest
technologies
hold
tremendous
promise
research.
In
review,
we
first
briefly
summarize
mechanisms
key
underlying
Ferroptosis
are
then
presented
to
delineate
their
design,
action,
applications.
Special
interest
is
placed
on
multifunctional
platforms.
Finally,
discuss
prospects
challenges
applications,
with
aim
providing
roadmap
theranostic
development
broad
range
ferroptosis‐related
diseases.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(38)
Published: July 12, 2023
Piezocatalytic
therapy,
which
generates
reactive
oxygen
species
(ROS)
under
mechanical
force,
has
garnered
extensive
attention
for
its
use
in
cancer
therapy
owing
to
deep
tissue
penetration
depth
and
less
O2
-dependence.
However,
the
piezocatalytic
therapeutic
efficiency
is
limited
poor
piezoresponse,
low
separation
of
electron-hole
pairs,
complicated
tumor
microenvironment
(TME).
Herein,
a
biodegradable,
porous
Mn-doped
ZnO
(Mn-ZnO)
nanocluster
with
enhanced
piezoelectric
effect
constructed
via
doping
engineering.
Mn-doping
not
only
induces
lattice
distortion
increase
polarization
but
also
creates
rich
vacancies
(OV
)
suppressing
recombination
leading
high-efficiency
generation
ROS
ultrasound
irradiation.
Moreover,
shows
TME-responsive
multienzyme-mimicking
activity
glutathione
(GSH)
depletion
ability
mixed
valence
Mn
(II/III),
further
aggravating
oxidative
stress.
Density
functional
theory
calculations
show
that
can
improve
performance
enzyme
Mn-ZnO
due
presence
OV
.
Benefiting
from
boosting
GSH
ability,
significantly
accelerate
accumulation
lipid
peroxide
inactivate
peroxidase
4
(GPX4)
induce
ferroptosis.
The
work
may
provide
new
guidance
exploring
novel
sonosensitizers
therapy.
Angewandte Chemie International Edition,
Journal Year:
2023,
Volume and Issue:
62(9)
Published: Jan. 2, 2023
Oxygen-deficient
molybdenum
oxide
(MoOX
)
nanomaterials
are
prepared
as
novel
nanosensitizers
and
TME-stimulants
for
ultrasound
(US)-enhanced
cancer
metalloimmunotherapy.
After
PEGylation,
MoOX
-PEG
exhibits
efficient
capability
US-triggered
reactive
oxygen
species
(ROS)
generation
glutathione
(GSH)
depletion.
Under
US
irradiation,
generates
a
massive
amount
of
ROS
to
induce
cell
damage
immunogenic
death
(ICD),
which
can
effectively
suppress
tumor
growth.
More
importantly,
itself
further
stimulates
the
maturation
dendritic
cells
(DCs)
triggeres
activation
cGAS-STING
pathway
enhance
immunological
effect.
Due
robust
ICD
induced
by
SDT
DC
stimulated
-PEG,
combination
treatment
-triggered
aCTLA-4
amplifies
antitumor
therapy,
inhibits
metastases,
elicits
immune
responses
defeat
abscopal
tumors.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(49)
Published: Sept. 10, 2023
Despite
its
remarkable
clinical
breakthroughs,
immune
checkpoint
blockade
(ICB)
therapy
remains
limited
by
the
insufficient
response
in
"cold"
tumor.
Nanozyme-based
antitumor
catalysis
is
associated
with
precise
activation
tumor
microenvironment
(TME).
In
this
study,
a
cascade-augmented
nanoimmunomodulator
(CMZM)
multienzyme-like
activities,
which
includes
superoxide
dismutase
(SOD),
catalase
(CAT),
peroxidase
(POD),
and
glutathione
oxidase
(GSHOx),
that
dissociates
under
an
acidic
abundant
GSH
TME,
proposed
for
multimodal
imaging-guided
chemodynamic
(CDT)/photodynamic
(PDT)
enhanced
immunotherapy.
Vigorous
activities
can
not
only
produce
O2
to
alleviate
hypoxia
promote
polarization
of
M2
M1
macrophages,
but
also
generate
ROS
(•OH
1
)
deplete
TME
expose
necrotic
cell
fragments
reverse
immunosuppressive
eliciting
maturation
dendritic
cells
infiltration
cytotoxic
T
lymphocytes
(CTLs)
tumors.
Therefore,
inhibitory
effects
on
both
primary
distant
tumors
are
achieved
through
synergy
α-PD-L1
blocking
antibody.
This
cascade
multienzyme-based
nanoplatform
provides
smart
strategy
highly
efficient
ICB
immunotherapy
against
revising
TME.
Exploration,
Journal Year:
2023,
Volume and Issue:
3(3)
Published: March 30, 2023
The
acidic
characteristic
of
the
tumor
site
is
one
most
well-known
features
and
provides
a
series
opportunities
for
cancer-specific
theranostic
strategies.
In
this
regard,
pH-responsive
nanoplatforms
that
integrate
diagnostic
therapeutic
capabilities
are
highly
developed.
fluidity
microenvironment
(TME),
with
its
temporal
spatial
heterogeneities,
makes
noninvasive
molecular
magnetic
resonance
imaging
(MRI)
technology
very
desirable
TME
constituents
developing
MRI-guided
tumor-specific
treatments.
Therefore,
various
MRI-based
strategies
which
employ
assorted
modes
have
been
drawn
up
more
efficient
cancer
therapy
through
raised
local
concentration
agents
in
pathological
tissues.
review,
we
summarize
mechanisms
organic
components
(including
polymers,
biological
molecules,
organosilicas)
as
well
inorganic
metal
coordination
compounds,
oxides,
salts)
nanoplatforms.
Furthermore,
review
designs
applications
diagnosis
treatment
cancer.
addition,
challenges
prospects
pH-responsiveness
discussed.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(16), P. 15328 - 15353
Published: Aug. 13, 2023
Ferroptosis,
a
type
of
regulated
cell
death
driven
by
iron-dependent
phospholipid
peroxidation,
has
captured
much
attention
in
the
field
nanomedicine
since
it
was
coined
2012.
Compared
with
other
modes
such
as
apoptosis
and
pyroptosis,
ferroptosis
many
distinct
features
molecular
mechanisms
cellular
morphology,
representing
promising
strategy
for
treating
cancers
that
are
resistant
to
conventional
therapeutic
modalities.
Moreover,
recent
insights
collectively
reveal
is
tightly
connected
maintenance
tumor
immune
microenvironment
(TIME),
suggesting
potential
application
therapies
evoking
robust
antitumor
immunity.
From
biochemical
perspective,
intricately
multiple
metabolic
pathways,
including
iron
metabolism,
lipid
redox
etc.,
highlighting
importance
elucidate
relationship
between
metabolism
developing
therapies.
In
this
review,
we
provide
comprehensive
discussion
on
current
understanding
ferroptosis-inducing
thoroughly
discuss
various
traits
tumors,
which
offer
opportunities
direct
inhibition
through
nanointegrated
approach.
Extending
from
complex
impact
TIME,
also
discussed
those
important
considerations
development
ferroptosis-based
immunotherapy,
challenges
strategies
enhance
ferroptosis-enabled
immunostimulatory
effects
while
avoiding
side
effects.
We
envision
study
may
facilitate
translation
nanomedicines
treatment.
Chemical Society Reviews,
Journal Year:
2023,
Volume and Issue:
52(18), P. 6447 - 6496
Published: Jan. 1, 2023
This
review
highlights
the
use
of
nanoprobes
to
stratify
various
therapeutic
modalities
and
provides
an
outlook
on
challenges
future
directions
for
patient
stratification.